SELECTIVE ACETYLENE OXIDATION IN GAS MIXTURES

    公开(公告)号:US20250162879A1

    公开(公告)日:2025-05-22

    申请号:US18743688

    申请日:2024-06-14

    Abstract: A feed stream is contacted with a metal oxide catalyst disposed within a reactor. The feed stream includes a mixture of gases. The mixture of gases includes acetylene. The metal oxide catalyst includes a metal oxide. In response to contacting the feed stream with the metal oxide catalyst, the acetylene of the feed stream is selectively oxidized to produce at least one of carbon monoxide or carbon dioxide. A product stream is discharged from the reactor. The product stream includes the at least one of the carbon monoxide or the carbon dioxide produced.

    Logic based ring oscillator coupling circuit

    公开(公告)号:US12261598B2

    公开(公告)日:2025-03-25

    申请号:US18349246

    申请日:2023-07-10

    Abstract: A coupled ring oscillator circuit includes a first ring oscillator, a second ring oscillator and a coupling circuit. The first ring oscillator includes a series of delay stages, each delay stage including an inverter gate. The second ring oscillator includes a series of delay stages, each delay stage including an inverter gate. The coupling circuit includes a coupling cell having a first modified tri-state inverter connected in parallel with one of the inverter gates of the first ring oscillator, and a second modified tri-state inverter connected in parallel with one of the inverter gates of the second ring oscillator.

    Skin care formulations and skin cancer treatment

    公开(公告)号:US12233073B2

    公开(公告)日:2025-02-25

    申请号:US16620382

    申请日:2018-06-08

    Abstract: An example technique for treating a skin cancer condition includes administering a therapeutically effective amount of a p53-related protein kinase (PRPK) inhibitor to a patient having skin cancer or having a high risk of developing skin cancer. An example composition includes a therapeutically effective amount of a PRPK inhibitor for treating a skin cancer condition. An example composition includes a pharmaceutically effective amount of at least one anti-solar ultraviolet (anti-sUV) combination for preventing a skin cancer condition. The at least one anti-sUV combination is chosen from the combinations: avobenzone and octinoxate; octocrylene and zinc oxide; avobenzone, octocrylene, and titanium dioxide; or avobenzone, octocrylene, and zinc oxide.

Patent Agency Ranking